Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated Mar 25, 2016 (11 years ago)

All Germall

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Lack of Processing Controls

Cause type: cGMP deviation

Departures from current Good Manufacturing Practice found in production or during FDA inspection. A broad quality-system cause: the batch was made under conditions that fall short of FDA manufacturing standards. All cgmp deviation recalls.

What was recalled

All Germall (diazolidinyl urea and iodopropynyl butylcarbamate) Products, Rx Only, Compounded by RELIABLE DRUG/RELIABLE COMPOUNDING PHARMACY, 801 Irving St., SAN FRANCISCO, CA 94122.

Drug: Urea

Recalling firm
Reliable Rexall-A Compounding Pharmacy
Origin
CA, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1077-2016 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other Urea recalls

See all
Class III · Low risk

Remeven Cream

Crystallization; Complaints that cream appears to have crystallized

Completed Failed specification Stratus Pharmaceuticals Inc D-1464-2016
Class II · Moderate risk

Carbo-O-Philic 40 Gel 40%

Marketed without an Approved NDA/ANDA: FDA has determined that the products are unapproved new drugs and misbranded.

Terminated Unapproved drug Geritrex Corp NDC 54162-016-15 D-0391-2016

Other recalls by Reliable Rexall-A Compounding Pharmacy

All 2016 recalls
Class II · Moderate risk

All Malarone

Lack of Processing Controls

Terminated cGMP deviation Reliable Rexall-A Compounding Pharmacy D-1136-2016